Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02978235
Title A Dose Finding Study Followed by a Safety and Efficacy Study for Patients With Multiple Myeloma or Lymphoma
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Taiho Oncology, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Center for Cancer and Blood Disorders Bethesda Maryland 20817 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Weisberg Cancer Treatment Center Farmington Hills Michigan 48334 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
John Theurer Cancer Center at Hackensack Meridian Health Hackensack New Jersey 07601 United States Details
Icahn School of Medicine at Mount Sinai New York New York 10029 United States Details
Gabrail Cancer Center Canton Ohio 44718 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field